The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
EGFRv3 and PTEN as prognostic markers in head and neck squamous cell carcinoma patients treated with cetuximab.
Alexandre Andre Balieiro Anastacio da Costa
No relevant relationships to disclose
Adriana Regina G. Ribeiro
No relevant relationships to disclose
Andrea Paiva Guimaraes
No relevant relationships to disclose
Ludmilla Thome Chinen
No relevant relationships to disclose
Clovis Pinto
No relevant relationships to disclose
Vladmir C. Lima
No relevant relationships to disclose